Search Reports
Categories
Categories

Global Positive Allosteric Modulators Market

Global Positive Allosteric Modulators Market Research Report 2025(Status and Outlook)

Report Code : SER2882
Published Date : 17 July, 1905 | No of Pages: 105

  • Report Description
  • Table of Contents
  • Companies Mentioned
  • Related Reports


Report Overview
Positive allosteric modulators (PAMs) are a class of pharmacological agents that enhance the activity of a target receptor or protein by binding to an allosteric site distinct from the orthosteric (active) site, thereby amplifying the effects of endogenous ligands without directly activating the receptor themselves. Unlike traditional agonists, PAMs offer greater selectivity and reduced risk of overstimulation, making them particularly valuable in therapeutic areas such as neurology (e.g., targeting GABA or glutamate receptors for epilepsy or cognitive disorders) and psychiatry (e.g., modulating dopamine or serotonin receptors for schizophrenia or depression). Their ability to fine-tune receptor activity while preserving physiological signaling patterns has positioned PAMs as a promising alternative in drug development, especially for conditions where conventional orthosteric drugs face limitations due to side effects or tolerance issues. The market for PAMs is driven by increasing research into central nervous system (CNS) disorders, a growing pipeline of preclinical and clinical candidates, and collaborations between pharmaceutical companies and academic institutions to explore novel mechanisms of action. However, challenges such as complex structure-activity relationships, potential off-target effects, and regulatory hurdles in demonstrating efficacy and safety in clinical trials may impact commercialization timelines. Despite these obstacles, the demand for PAMs is expected to rise, supported by advancements in structural biology, high-throughput screening, and a shift toward precision medicine in treating complex diseases.

This report provides a deep insight into the global Positive Allosteric Modulators market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Positive Allosteric Modulators Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Positive Allosteric Modulators market in any manner.
Global Positive Allosteric Modulators Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
F. Hoffmann-La Roche
Pfizer
Taj Pharmaceuticals
Explicit Chemicals
Shaanxi Rebecca Bio-Tech
Zydus Cadila
ACADIA Pharmaceuticals
M Somerset Pharmaceuticals
Vertical Pharmaceuticals

Market Segmentation (by Type)
Benzodiazepines
Barbiturates
Amantadine
Other

Market Segmentation (by Application)
Parkinson’s Disease
Schizophrenia
Alzheimer’s Disease

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Positive Allosteric Modulators Market
Overview of the regional outlook of the Positive Allosteric Modulators Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Positive Allosteric Modulators Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market\'s competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter\'s five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Positive Allosteric Modulators, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



  Table of Contents
  1 Research Methodology and Statistical Scope
      1.1 Market Definition and Statistical Scope of Positive Allosteric Modulators
      1.2 Key Market Segments
            1.2.1 Positive Allosteric Modulators Segment by Type
            1.2.2 Positive Allosteric Modulators Segment by Application
      1.3 Methodology & Sources of Information
            1.3.1 Research Methodology
            1.3.2 Research Process
            1.3.3 Market Breakdown and Data Triangulation
            1.3.4 Base Year
            1.3.5 Report Assumptions & Caveats
  2 Positive Allosteric Modulators Market Overview
      2.1 Global Market Overview
      2.2 Market Segment Executive Summary
      2.3 Global Market Size by Region
  3 Positive Allosteric Modulators Market Competitive Landscape
      3.1 Company Assessment Quadrant
      3.2 Global Positive Allosteric Modulators Product Life Cycle
      3.3 Global Positive Allosteric Modulators Revenue Market Share by Company (2020-2025)
      3.4 Positive Allosteric Modulators Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
      3.5 Positive Allosteric Modulators Company Headquarters, Area Served, Product Type
      3.6 Positive Allosteric Modulators Market Competitive Situation and Trends
            3.6.1 Positive Allosteric Modulators Market Concentration Rate
            3.6.2 Global 5 and 10 Largest Positive Allosteric Modulators Players Market Share by Revenue
            3.6.3 Mergers & Acquisitions, Expansion
  4 Positive Allosteric Modulators Value Chain Analysis
      4.1 Positive Allosteric Modulators Value Chain Analysis
      4.2 Midstream Market Analysis
      4.3 Downstream Customer Analysis
  5 The Development and Dynamics of Positive Allosteric Modulators Market
      5.1 Key Development Trends
      5.2 Driving Factors
      5.3 Market Challenges
      5.4 Industry News
            5.4.1 New Product Developments
            5.4.2 Mergers & Acquisitions
            5.4.3 Expansions
            5.4.4 Collaboration/Supply Contracts
      5.5 PEST Analysis
            5.5.1 Industry Policies Analysis
            5.5.2 Economic Environment Analysis
            5.5.3 Social Environment Analysis
            5.5.4 Technological Environment Analysis
      5.6 Global Positive Allosteric Modulators Market Porter's Five Forces Analysis
  6 Positive Allosteric Modulators Market Segmentation by Type
      6.1 Evaluation Matrix of Segment Market Development Potential (Type)
      6.2 Global Positive Allosteric Modulators Market Size Market Share by Type (2020-2025)
      6.3 Global Positive Allosteric Modulators Market Size Growth Rate by Type (2021-2025)
  7 Positive Allosteric Modulators Market Segmentation by Application
      7.1 Evaluation Matrix of Segment Market Development Potential (Application)
      7.2 Global Positive Allosteric Modulators Market Size (M USD) by Application (2020-2025)
      7.3 Global Positive Allosteric Modulators Sales Growth Rate by Application (2020-2025)
  8 Positive Allosteric Modulators Market Segmentation by Region
      8.1 Global Positive Allosteric Modulators Market Size by Region
            8.1.1 Global Positive Allosteric Modulators Market Size by Region
            8.1.2 Global Positive Allosteric Modulators Market Size Market Share by Region
      8.2 North America
            8.2.1 North America Positive Allosteric Modulators Market Size by Country
            8.2.2 U.S.
            8.2.3 Canada
            8.2.4 Mexico
      8.3 Europe
            8.3.1 Europe Positive Allosteric Modulators Market Size by Country
            8.3.2 Germany
            8.3.3 France
            8.3.4 U.K.
            8.3.5 Italy
            8.3.6 Spain
      8.4 Asia Pacific
            8.4.1 Asia Pacific Positive Allosteric Modulators Market Size by Region
            8.4.2 China
            8.4.3 Japan
            8.4.4 South Korea
            8.4.5 India
            8.4.6 Southeast Asia
      8.5 South America
            8.5.1 South America Positive Allosteric Modulators Market Size by Country
            8.5.2 Brazil
            8.5.3 Argentina
            8.5.4 Columbia
      8.6 Middle East and Africa
            8.6.1 Middle East and Africa Positive Allosteric Modulators Market Size by Region
            8.6.2 Saudi Arabia
            8.6.3 UAE
            8.6.4 Egypt
            8.6.5 Nigeria
            8.6.6 South Africa
  9 Key Companies Profile
      9.1 F. Hoffmann-La Roche
            9.1.1 F. Hoffmann-La Roche Basic Information
            9.1.2 F. Hoffmann-La Roche Positive Allosteric Modulators Product Overview
            9.1.3 F. Hoffmann-La Roche Positive Allosteric Modulators Product Market Performance
            9.1.4 F. Hoffmann-La Roche SWOT Analysis
            9.1.5 F. Hoffmann-La Roche Business Overview
            9.1.6 F. Hoffmann-La Roche Recent Developments
      9.2 Pfizer
            9.2.1 Pfizer Basic Information
            9.2.2 Pfizer Positive Allosteric Modulators Product Overview
            9.2.3 Pfizer Positive Allosteric Modulators Product Market Performance
            9.2.4 Pfizer SWOT Analysis
            9.2.5 Pfizer Business Overview
            9.2.6 Pfizer Recent Developments
      9.3 Taj Pharmaceuticals
            9.3.1 Taj Pharmaceuticals Basic Information
            9.3.2 Taj Pharmaceuticals Positive Allosteric Modulators Product Overview
            9.3.3 Taj Pharmaceuticals Positive Allosteric Modulators Product Market Performance
            9.3.4 Taj Pharmaceuticals SWOT Analysis
            9.3.5 Taj Pharmaceuticals Business Overview
            9.3.6 Taj Pharmaceuticals Recent Developments
      9.4 Explicit Chemicals
            9.4.1 Explicit Chemicals Basic Information
            9.4.2 Explicit Chemicals Positive Allosteric Modulators Product Overview
            9.4.3 Explicit Chemicals Positive Allosteric Modulators Product Market Performance
            9.4.4 Explicit Chemicals Business Overview
            9.4.5 Explicit Chemicals Recent Developments
      9.5 Shaanxi Rebecca Bio-Tech
            9.5.1 Shaanxi Rebecca Bio-Tech Basic Information
            9.5.2 Shaanxi Rebecca Bio-Tech Positive Allosteric Modulators Product Overview
            9.5.3 Shaanxi Rebecca Bio-Tech Positive Allosteric Modulators Product Market Performance
            9.5.4 Shaanxi Rebecca Bio-Tech Business Overview
            9.5.5 Shaanxi Rebecca Bio-Tech Recent Developments
      9.6 Zydus Cadila
            9.6.1 Zydus Cadila Basic Information
            9.6.2 Zydus Cadila Positive Allosteric Modulators Product Overview
            9.6.3 Zydus Cadila Positive Allosteric Modulators Product Market Performance
            9.6.4 Zydus Cadila Business Overview
            9.6.5 Zydus Cadila Recent Developments
      9.7 ACADIA Pharmaceuticals
            9.7.1 ACADIA Pharmaceuticals Basic Information
            9.7.2 ACADIA Pharmaceuticals Positive Allosteric Modulators Product Overview
            9.7.3 ACADIA Pharmaceuticals Positive Allosteric Modulators Product Market Performance
            9.7.4 ACADIA Pharmaceuticals Business Overview
            9.7.5 ACADIA Pharmaceuticals Recent Developments
      9.8 M Somerset Pharmaceuticals
            9.8.1 M Somerset Pharmaceuticals Basic Information
            9.8.2 M Somerset Pharmaceuticals Positive Allosteric Modulators Product Overview
            9.8.3 M Somerset Pharmaceuticals Positive Allosteric Modulators Product Market Performance
            9.8.4 M Somerset Pharmaceuticals Business Overview
            9.8.5 M Somerset Pharmaceuticals Recent Developments
      9.9 Vertical Pharmaceuticals
            9.9.1 Vertical Pharmaceuticals Basic Information
            9.9.2 Vertical Pharmaceuticals Positive Allosteric Modulators Product Overview
            9.9.3 Vertical Pharmaceuticals Positive Allosteric Modulators Product Market Performance
            9.9.4 Vertical Pharmaceuticals Business Overview
            9.9.5 Vertical Pharmaceuticals Recent Developments
  10 Positive Allosteric Modulators Market Forecast by Region
      10.1 Global Positive Allosteric Modulators Market Size Forecast
      10.2 Global Positive Allosteric Modulators Market Forecast by Region
            10.2.1 North America Market Size Forecast by Country
            10.2.2 Europe Positive Allosteric Modulators Market Size Forecast by Country
            10.2.3 Asia Pacific Positive Allosteric Modulators Market Size Forecast by Region
            10.2.4 South America Positive Allosteric Modulators Market Size Forecast by Country
            10.2.5 Middle East and Africa Forecasted Sales of Positive Allosteric Modulators by Country
  11 Forecast Market by Type and by Application (2026-2033)
      11.1 Global Positive Allosteric Modulators Market Forecast by Type (2026-2033)
      11.2 Global Positive Allosteric Modulators Market Forecast by Application (2026-2033)
  12 Conclusion and Key Findings
F. Hoffmann-La Roche
Pfizer
Taj Pharmaceuticals
Explicit Chemicals
Shaanxi Rebecca Bio-Tech
Zydus Cadila
ACADIA Pharmaceuticals
M Somerset Pharmaceuticals
Vertical Pharmaceuticals
Please select License
Single User Price:$ 3200
Site License Price:$ 6400
Enterprise Price:$ 6400